Navigation Links
Stimulant Medications More Effective In Treating ADHD Than Nonstimulants

Children with ADHD responded positively when treated with stimulant medications rather than nonstimulant medications or novel stimulants//. Researchers have proved that stimulant medications, such as mixed amphetamine salts (MAS) and methylphenidates are significantly more effective when compared with nonstimulant medications such as modafinil.

This conclusion is based on a meta-analysis of 29 controlled-treatment studies representing the past 25 years of research involving nearly 4,500 children with ADHD presented recently at the 2006 American Psychiatric Association meeting in Toronto, Canada.

Among stimulant medications classes, long-acting mixed amphetamine salts (MAS XR) and immediate-release mixed amphetamine salts showed a similar level of efficacy to short- or long-acting methylphenidates. The effectiveness of short- and long-acting stimulants did not differ from one another.

“The larger effect sizes we calculated for stimulant ADHD medications, compared to nonstimulants or the novel stimulant modafinil, leads us to conclude that amphetamine and methylphenidate based stimulant medications are more effective in treating symptoms of ADHD,” said Stephen V. Faraone, Ph.D., lead researcher and director of child and adolescent psychiatry at SUNY Upstate Medical University. “Our results should help physicians who have had to rely on qualitative comparisons among published trials, along with their own clinical experience, to draw conclusions about an ADHD medication’s relative efficacy because of largely absent direct head-to-head drug comparisons.”

The researchers compared study outcomes using effect sizes, a commonly used, standard statistical measure to determine the magnitude of a particular effect resulting from an intervention, such as a drug used on a population, irrespective of the population size. Effect sizes are generally categorized as small (0.2), medium (0.5) and large (0.8). Standardized mean averages, or effect sizes, for dependent measures in each study were computed by taking the mean of the active drug group minus the mean of the placebo group and dividing the result by the pooled standard deviation of the groups.

After adjusting for the influence of individual study design features, the researchers calculated effect size based on Total ADHD scores. Long-acting and short-acting stimulant medications showed the largest effect size among all medications (E = 0.83 and E = 0.9 respectively), followed by nonstimulant or modafinil based stimulants medications (E = 0.62). Statistically significant differences in effect size occurred in comparisons between nonstimulant/modafinil based stimulant medications and long-acting (p = 0.004) as well as short-acting stimulants (p = 0.002).

For the analysis, Faraone and his colleagues used data from 29 double-blind, placebo-controlled treatment studies of 4,465 children with ADHD, with an average age 10 years, published during or after 1980. Designs for all of the studies were randomized, double-blind with placebo controls that lasted for two or more weeks in populations diagnosed with ADHD as defined using criteria from the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition or Fourth Edition (DSM).

The analysis included 15 drugs using 17 different outcome measures of ADHD symptoms, including hyperactive, inattentive, impulsive or oppositional behavior. The most commonly identified treatments included both methylphenidate and amphetamine compounds. Nonstimulant drugs included in the analysis were atomoxetine, bupropion, modafinil and desipramine.

Source: Newsise
'"/>




Related medicine news :

1. Stimulants like coffee can help in reducing liver disease
2. Cocaine Acts As Suppressant Not Stimulant In Genetically Altered Mice
3. Coffee Stimulants Could Make us to Change The Attitude
4. Growth Hormone Stimulant Packs Healthy Aging
5. Growth Hormone Stimulants help to Combat Aging Symptoms
6. What happens when Medications go wrong?
7. Medications to Prevent Relapse to Cocaine Use
8. More Elderly Take Inappropriate and Harmful Medications
9. Medications for depression
10. Medications linked to xerostomia and caries
11. Analyzing The Side Effects Of Some Common Medications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
Breaking Medicine Technology: